Track CPMD and 10,000+ stocks
Create a free account to build watchlists, compare peers, and value any stock.
- Build and track watchlists
- Compare against peers
- Earnings & price alerts
No credit card required
Create a free account to build watchlists, compare peers, and value any stock.
No credit card required
CPMD (CPMD) has a revenue of $1.36M, up 66.1% over the past year and up 1000.0% per year over the past five years.
Revenue TTM
$1.36M
5Y CAGR
1000.00%
3Y CAGR
1000.00%
Gross Margin
-153.09%
| Year | Revenue | Change |
|---|---|---|
| 2025 | $1.36M | +66.09% |
| 2024 | $820.14K | +3186.60% |
| 2023 | $24.95K | - |
| 2022 | $0.00 | - |
| 2021 | $0.00 | - |
| 2020 | $0.00 | - |
| 2019 | $0.00 | -100.00% |
| 2018 | $7.50K | - |
| Quarter | Revenue | Change |
|---|---|---|
| Q4 2025 | $138.63K | -78.89% |
| Q3 2025 | $656.61K | +183.50% |
| Q2 2025 | $231.61K | -30.93% |
| Q1 2025 | $335.32K | -30.45% |
| Q4 2024 | $482.13K | +54.45% |
| Q3 2024 | $312.16K | - |
| Q2 2024 | $0.00 | -100.00% |
| Q1 2024 | $25.84K | - |
| Q4 2023 | $0.00 | - |
| Q3 2023 | $0.00 | -100.00% |
| Q2 2023 | $24.95K | - |
| Q1 2023 | $0.00 | - |
| Q4 2022 | $0.00 | - |
| Q3 2022 | $0.00 | - |
| Q2 2022 | $0.00 | - |
| Q1 2022 | $0.00 | - |
| Q4 2021 | $0.00 | - |
| Q3 2021 | $0.00 | - |
| Q2 2021 | $0.00 | - |
| Q1 2021 | $0.00 | - |
| Q4 2020 | $0.00 | - |
| Q3 2020 | $0.00 | - |
| Q2 2020 | $0.00 | - |
| Q1 2020 | $0.00 | - |
| Q4 2019 | $0.00 | - |
| Q3 2019 | $0.00 | - |
| Q2 2019 | $0.00 | - |
| Q1 2019 | $0.00 | - |
| Q4 2018 | $0.00 | - |
| Q3 2018 | $0.00 | -100.00% |
| Q2 2018 | $7.50K | - |
| Q1 2018 | $0.00 | - |
| Q4 2017 | $0.00 | - |
| Q3 2017 | $0.00 | - |
| Q3 2015 | $0.00 | - |
| Q2 2015 | $0.00 | - |
| Q1 2015 | $0.00 | - |
| Q4 2014 | $0.00 | - |
| Q3 2014 | $0.00 | - |
| Q2 2014 | - | - |
Revenue — often called the top line — is the total amount a company earns from selling its products and services before any expenses are deducted. Consistent revenue growth is a core signal of expanding demand and a healthy business.